The renin-angiotensin system (RAS) remains a cornerstone of cardiovascular and renal physiology, orchestrating vital aspects of blood pressure regulation and fluid-electrolyte balance. At the heart of ...

The renin–angiotensin system (RAS) is a highly regulated hormonal cascade that plays a central role in the control of blood pressure and the maintenance of renal homeostasis. Its components, including ...

Treatments that target the renin-angiotensin-aldosterone system (RAAS) don’t improve outcomes in adult patients hospitalized with acute COVID-19. Three separate trials of different RAAS-related ...

In a recent study posted to the medRxiv* preprint server, researchers conducted an umbrella review and meta-analysis of the renin-angiotensin-aldosterone system (RAAS) inhibitors' impact on ...

Unique Characteristics of Hypertension in Blacks That Influence BP Responses to Drugs That Block the Renin-Angiotensin Activating System (RAAS) Blockade of the RAAS in Blacks for Cardiovascular and ...

Key parameters that influence surgical strategy in localised kidney cancer. Association of ACEI/ARB with tumor regression.

The rapid outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in the pandemic of the ongoing coronavirus disease 2019 (COVID-19). To date, this pandemic has claimed ...

In patients with mild or moderate chronic kidney disease, renin–angiotensin system inhibitors have improved outcomes, but less evidence supports their use in advanced CKD. New research findings are ...

This uncontrolled degradation disrupts the renin-angiotensin-aldosterone system (RAAS), potentially leading to cardiovascular collapse accompanied by organ failure and ultimately, death. Procizumab is ...

In this randomized trial, the discontinuation of renin–angiotensin system inhibitors in patients with advanced chronic kidney disease did not lead to a significant between-group difference in the long ...